评估机器学习和可穿戴设备在终身护理中的潜力,预测末期癌症患者7天死亡事件:队列研究
Jen-Hsuan Liu1,2,3, Chih-Yuan Shih3,4, Hsien-Liang Huang3,4
1Department of Family Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.
Journal of medical Internet research
|August 18, 2023
概括
使用人工智能和可穿戴设备预测癌症患者的死亡率显示出有希望. 智能手表数据准确地预测7天内死亡事件,增强终身护理和个性化治疗策略.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 医疗信息学 医疗信息学
- 在瘤学中使用人工智能
背景情况:
- 在终身护理中准确预测死亡率具有挑战性,现有的工具表现中等,主要是在医院环境中.
- 目前的预后工具可能无法捕捉到接受终身护理的患者的多样性轨迹.
- 对生命末期癌症患者的人工智能 (AI) 和可穿戴设备的证据有限.
研究的目的:
- 研究可穿戴设备和人工智能的使用,以预测生命末期癌症患者的死亡事件.
- 确定连续的智能手表监控是否可以提供对患者进展的见解,并帮助个性化护理,特别是在门诊或家庭环境中.
主要方法:
- 台湾国立大学医院的一项前性研究,涉及接受终身护理的癌症患者.
- 智能手表收集生理数据 (步骤,心率,睡眠,血液氧气);每周进行临床评估.
- 机器学习模型,包括深度神经网络,使用收集的数据和临床评估预测7天死亡事件.
主要成果:
- 极端梯度增强 (XGBoost) 模型实现了高性能:96%的AUROC,78.5%的F1得分,93%的精度和97%的特异性.
- 平均心率是最重要的预测因素,其次是所采取的步骤,食欲,排尿状态和临床护理阶段.
- 该研究分析了40名患者的1657个数据点,检测了28例死亡事件,平均存活时间为34天.
结论:
- 人工智能和可穿戴设备可以在7天内成功预测患者的死亡.
- 整合人工智能和可穿戴技术为临床决策提供了有价值的见解.
- 需要进一步的研究来验证这些发现在更大的队列中,并评估临床影响.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
06:49Evaluation of a Smartphone-based Human Activity Recognition System in a Daily Living Environment
Published on: December 11, 2015
8.9K
相关概念视频
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Kaplan-Meier Approach
179
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
179
